Literature DB >> 16756777

Clinico-pathologic features of chronic myeloid leukemia and risk stratification according to Sokal score.

Naveen Naz Syed1, Muhammad Usman, Gulnaz Khaliq, Salman N Adil, Muhamamd Khurshid.   

Abstract

OBJECTIVE: To compile the clinical and haematological parameters of chronic myeloid leukemia (CML) and risk stratification according to Sokal score in our population.
DESIGN: A descriptive analysis. PLACE AND DURATION OF STUDY: The Aga Khan University Hospital, during the period from August 1997 to August 2005. SUBJECTS AND METHODS: All patients with diagnosis of chronic myeloid leukemia treated as outpatient in haematology clinic, or admitted in haem-oncology wards in The Aga Khan University Hospital were included. Records were retrospectively analyzed for clinicopathologic features. Risk groups were assigned as per Sokal scoring.
RESULTS: During the 8 years study period, 245 patients with chronic myeloid leukemia were analyzed, the median age of presentation was 35 years (range 11-73); with male to female ratio 1.69:1. At the time of diagnosis, 178 patients (72.6%), 48 (19.7%) and 17 (7.8%) of patients were in chronic, accelerated and blast phase of the disease respectively. Abdominal fullness was the frequent clinical presentation followed by fever. Laboratory parameters revealed mean hemoglobin 10.0 g/dl (range 4.6-15), mean total leukocyte count 168 x 10(9)/L (35-959) and mean platelets 408 x 10(9)/L (range 30-2335). The mean size of spleen at the time of presentation was 9.2 cm below the left subcostal margin. A large number of patients (46.2%) were in high risk group according to Sokal score i.e. > 1.2.
CONCLUSION: CML occurred more commonly at younger age in this series. Most of these patients were in high risk group according to Sokal score.

Entities:  

Mesh:

Year:  2006        PMID: 16756777     DOI: 5.2006/JCPSP.336339

Source DB:  PubMed          Journal:  J Coll Physicians Surg Pak        ISSN: 1022-386X            Impact factor:   0.711


  6 in total

1.  Chronic myeloid leukemia with variation of translocation at (Ph) [ins (22;9) (q11;q21q34)]: a case report.

Authors:  Zhiqiong Wang; Wen Zen; Fankai Meng; Xing Xin; Li Luo; Hanying Sun; Jianfeng Zhou; Lifang Huang
Journal:  Int J Clin Exp Pathol       Date:  2015-10-01

2.  "Preleukemic or smoldering" chronic myelogenous leukemia (CML):BCR-ABL1 positive: A brief case report.

Authors:  John M Bennett; Kevin G Dsouza; Mehul Patel; Kristen O'Dwyer
Journal:  Leuk Res Rep       Date:  2014-12-19

3.  Risk Stratification of Chronic Myeloid Leukemia According to Different Prognostic Scores.

Authors:  Javeria Aijaz; Nada Junaid; Muhammad Asif Naveed; Rafeeda Maab
Journal:  Cureus       Date:  2020-03-20

4.  Serum concentrations of nitrite and malondialdehyde as markers of oxidative stress in chronic myeloid leukemia patients treated with tyrosine kinase inhibitors.

Authors:  Maria Juracy Petrola; Alana Joselina Montenegro de Castro; Maria Helena da Silva Pitombeira; Maritza Cavalcante Barbosa; Acy Telles de Souza Quixadá; Fernando Barroso Duarte; Romelia Pinheiro Gonçalves
Journal:  Rev Bras Hematol Hemoter       Date:  2012

5.  Phase distribution of chronic myeloid leukemia in Bangladesh.

Authors:  Md Abdul Mottalib; Tanvira Afroze Sultana; Md Ibrahim Khalil; Siew Hua Gan; Md Sirazul Islam; Subhagata Choudhury; M Anwar Hossain
Journal:  BMC Res Notes       Date:  2014-03-13

6.  Additional chromosomal abnormalities in Philadelphia positive chronic myeloid leukemia.

Authors:  Sunila Tashfeen; Rafia Mahmood; Saleem Ahmed Khan; Tahir Khadim
Journal:  Pak J Med Sci       Date:  2020 Jan-Feb       Impact factor: 1.088

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.